Clinical trial
Immunogenicity and Tolerability Study of FluvalAB FL-K-004 Trivalent Influenza Vaccine With 6 Mcg HA/Strain/Dos Antigen Content
NCT00778297 is registered in ClinicalTrials.gov with Fluart Innovative Vaccine Ltd, Hungary as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Immunogenicity and Tolerability Study of FluvalAB FL-K-004 Trivalent Influenza Vaccine With 6 Mcg HA/Strain/Dos Antigen Content
- Lead sponsor
- Fluart Innovative Vaccine Ltd, Hungary
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 30, 2007
- Completion date
- May 31, 2008
- Enrollment
- 234 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
influenza